#BEGIN_DRUGCARD DB04731

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C7H17NO7P

# Chemical_IUPAC_Name:
[(2S)-3-(acetyloxy)-2-hydroxypropoxy](2-azaniumylethoxy)phosphinic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2007-09-11 11:49:32 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
1-ACETYL-2-LYSO-SN-GLYCERO-3-PHOSPHOETHANOLAMINE

# HET_ID:
LSP

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C7H16NO7P/c1-6(9)13-4-7(10)5-15-16(11,12)14-3-2-8/h7,10H,2-5,8H2,1H3,(H,11,12)/p+1/t7-/m0/s1

# InChI_Key:
InChIKey=CWRILEGKIAOYKP-ZETCQYMHSA-O

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4731

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
258.1861

# Molecular_Weight_Mono:
258.074263415

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.8

# Predicted_LogS:
-1.2

# Predicted_Water_Solubility:
1.67e+01 g/l

# Primary_Accession_No:
DB04731

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
6102806

# PubChem_Substance_ID:
46508927

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
Not Available

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CC(=O)OC[C@H](O)CO[P@](O)(=O)OCC[NH3+]

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:38 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
Not Available

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
X58545

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
cinA

# Drug_Target_1_Gene_Sequence:
>237 bp
ATGACCGCTTCCATTCTTCAGCAGTCCGTCGTGGACGCCGACTTCCGCGCGGCGCTGCTT
GAGAACCCCGCCGCCTTCGGCGCTTCCGCCGCGGCCCTGCCCACGCCCGTCGAGGCCCAG
GACCAGGCGTCCCTTGACTTCTGGACCAAGGACATCGCCGCCACGGAAGCCTTCGCCTGC
CGCCAGAGCTGCAGCTTCGGCCCGTTCACCTTCGTGTGCGACGGCAACACCAAGTAA

# Drug_Target_1_General_Function:
Not Available

# Drug_Target_1_General_References:
2070795	Kaletta C, Entian KD, Jung G: Prepeptide sequence of cinnamycin (Ro 09-0198): the first structural gene of a duramycin-type lantibiotic. Eur J Biochem. 1991 Jul 15;199(2):411-5.
2125590	Fredenhagen A, Fendrich G, Marki F, Marki W, Gruner J, Raschdorf F, Peter HH: Duramycins B and C, two new lanthionine containing antibiotics as inhibitors of phospholipase A2. Structural revision of duramycin and cinnamycin. J Antibiot (Tokyo). 1990 Nov;43(11):1403-12.
2544544	Naruse N, Tenmyo O, Tomita K, Konishi M, Miyaki T, Kawaguchi H, Fukase K, Wakamiya T, Shiba T: Lanthiopeptin, a new peptide antibiotic. Production, isolation and properties of lanthiopeptin. J Antibiot (Tokyo). 1989 Jun;42(6):837-45.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
5750

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
8205

# Drug_Target_1_Name:
Lantibiotic cinnamycin

# Drug_Target_1_Number_of_Residues:
78

# Drug_Target_1_PDB_ID:
Not Available

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
Not Available

# Drug_Target_1_Protein_Sequence:
>Lantibiotic cinnamycin
MTASILQQSVVDADFRAALLENPAAFGASAAALPTPVEAQDQASLDFWTKDIAATEAFAC
RQSCSFGPFTFVCDGNTK

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Can act as inhibitor of the enzyme phospholipase A2, and of the angiotensin-converting enzyme. Shows inhibitory activities against herpes simplex virus and immunopotentiating activities. Its antimicrobial activities are not very pronounced

# Drug_Target_1_SwissProt_ID:
P29827

# Drug_Target_1_SwissProt_Name:
CINA_STRGV

# Drug_Target_1_Synonyms:
Lanthiopeptin
Lantibiotic Ro 09- 0198
Lantibiotic cinnamycin precursor

# Drug_Target_1_Theoretical_pI:
3.93

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB04731
